Skip to main content
. 2021 May 25;74(1):172–179. doi: 10.1007/s12020-021-02750-w

Table 5.

Non-endocrine-related toxicities in the subgroup of patients with NSCLC (n = 92) treated with immunotherapy

Toxicity Number of cases
Fatigue 31
Skin rash 18
Itchiness 16
Diarrhea 15
Hypertransaminasemia/hyperbilirubinemia 11
Pneumonia 10
Hyporexia/anorexia 10
Arthritis 8
Mucositis 7
Fever 6
Nausea 6
Myalgia 4
Xerostomia 3